Association of Papillary Thyroid Carcinoma with Primary Aldosteronism
- PMID: 30333389
- PMCID: PMC6421148
- DOI: 10.2169/internalmedicine.0891-18
Association of Papillary Thyroid Carcinoma with Primary Aldosteronism
Abstract
Objective The association of primary aldosteronism (PA) with thyroid disease has already been suggested. The aim of this study was to examine the presence of PA in patients with papillary thyroid carcinoma (PC) and to characterize such PC patients with PA. Methods We examined the presence of PA in 81 consecutive patients with PC, whose random sitting blood pressure (BP) was ≥140/90 mmHg in the office (n= 68), who had an incidental adrenal tumor or adrenal enlargement (n=9), or who showed hypokalemia (n=4). Thirty-one of these 81 patients had been treated with anti-hypertensive drugs. The plasma aldosterone concentration (PAC) and plasma renin activity (PRA) were first measured before operation in 16 patients and after operation in 65 patients. PA was diagnosed according to the guidelines of the Japan Endocrine Society. Results Forty patients with PC with a random PAC/PRA ratio of over 200 were subjected to a further study (12 of these patients had been treated with anti-hypertensive drugs). Ultimately, 15 patients with PC were diagnosed with PA. Adrenal venous sampling was done in 9 out of 15 patients with PC associated with PA. No patients were diagnosed as having unilateral lesions. Among the 15 patients, white-coat hypertension was observed in 5 patients, and normotension was observed in 1 patient. Conclusion These findings suggest that the prevalence of PA may be high among patients with PC. An active examination is needed to detect PA, as its signs and symptoms may be mild in patients with PC associated with hypertension.
Keywords: papillary thyroid carcinoma; primary aldosteronism; white-coat hypertension.
Conflict of interest statement
Figures

Similar articles
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
-
Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism.J Clin Endocrinol Metab. 2003 Jun;88(6):2489-94. doi: 10.1210/jc.2002-021476. J Clin Endocrinol Metab. 2003. PMID: 12788844
-
Primary aldosteronism in normokalemic patients with adrenal incidentalomas.Eur J Endocrinol. 2002 Apr;146(4):523-9. doi: 10.1530/eje.0.1460523. Eur J Endocrinol. 2002. PMID: 11916621
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
-
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.Ann Endocrinol (Paris). 2016 Jul;77(3):179-86. doi: 10.1016/j.ando.2016.05.001. Epub 2016 Jun 15. Ann Endocrinol (Paris). 2016. PMID: 27315757
Cited by
-
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures.Int J Mol Sci. 2024 Jan 6;25(2):754. doi: 10.3390/ijms25020754. Int J Mol Sci. 2024. PMID: 38255827 Free PMC article.
References
-
- Shimamoto K, Ando K, Fujita T, et al. . The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 37: 253-392, 2014. - PubMed
-
- Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202, 2004. - PubMed
-
- Miyake Y, Tanaka K, Nishikawa T, et al. . Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocr J 61: 35-40, 2014. - PubMed
-
- Funder JW, Carey RM, Mantero F, et al. . The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101: 1889-1916, 2016. - PubMed
-
- Armanini D, Nacamulli D, Scaroni C, et al. . High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism. Endocrine 22: 155-159, 2003. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials